W. Schillinger et al., UNALTERED RYANODINE RECEPTOR PROTEIN-LEVELS IN ISCHEMIC CARDIOMYOPATHY, Molecular and cellular biochemistry, 161, 1996, pp. 297-302
Previous studies on sarcoplasmic reticulum calcium release channel (ry
anodine receptor) demonstrated that protein levels are unchanged in my
ocardium from hearts with end-stage failing dilated cardiomyopathy. In
ischemic cardiomyopathy, ryanodine receptor mRNA levels were shown to
be decreased but no data on protein levels are available. Accordingly
, protein levels of ryanodine receptor, calsequestrin, and sarcoplasmi
c reticulum calcium-ATPase (SR-Ca2+-ATPase) were measured by Western b
lot analysis in nonfailing human myocardium (n = 7) and in end-stage f
ailing myocardium due to ischemic cardiomyopathy (n = 14). Protein lev
els of calsequestrin which is the major sarcoplasmic reticulum calcium
storage protein were similar in nonfailing myocardium and in myocardi
um from end-stage failing hearts with ischemic cardiomyopathy. Ryanodi
ne receptor protein levels, normalized to total protein or calsequestr
in were also unchanged in ischemic cardiomyopathy. In contrast, protei
n levels of SR-Ca2+-ATPase normalized to total protein or calsequestri
n were decreased by 31 and 30%, respectively (p < 0.05). The data indi
cate that (1) sarcoplasmic reticulum calcium uptake sites are decrease
d relative to the release sites in ischemic cardiomyopathy, and (2) al
terations of sarcoplasmic proteins are similar in ischemic and dilated
cardiomyopathy.